1. Home
  2. AORT

as 05-29-2024 2:30pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Medical/Dental Instruments

Nasdaq

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.

Founded: 1984 Country:
United States
United States
Employees: N/A City: KENNESAW
Market Cap: 992.4M IPO Year: 1993
Target Price: $27.50 AVG Volume (30 days): 186.6K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.24 EPS Growth: N/A
52 Week Low/High: $12.16 - $25.51 Next Earning Date: 05-06-2024
Revenue: $368,206,000 Revenue Growth: 15.13%
Revenue Growth (this year): 12.74% Revenue Growth (next year): 9.75%

Stock Insider Trading Activity of Artivion Inc. (AORT)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Holloway Jean F AORT SVP, General Counsel May 9 '24 Sell $23.79 979 $23,285.52 168,732 SEC Form 4
Getz Matthew A AORT VP, Human Resources Mar 12 '24 Sell $19.94 5,000 $99,719.50 43,536 SEC Form 4
Getz Matthew A AORT VP, Human Resources Mar 1 '24 Sell $18.72 1,157 $21,661.35 48,536 SEC Form 4
Mackin James P AORT President & CEO Mar 1 '24 Sell $18.72 13,996 $262,037.31 706,038 SEC Form 4
Mackin James P AORT President & CEO Mar 1 '24 Sell $18.72 13,996 $262,037.31 705,562 SEC Form 4
Holloway Jean F AORT SVP, General Counsel Mar 1 '24 Sell $18.72 2,380 $44,558.84 169,669 SEC Form 4
Davis John E AORT Chief Commercial Officer Mar 1 '24 Sell $18.72 2,022 $37,856.29 165,637 SEC Form 4
Davis John E AORT Chief Commercial Officer Mar 1 '24 Sell $18.72 2,022 $37,856.29 165,690 SEC Form 4
Getz Matthew A AORT VP, Human Resources Mar 1 '24 Sell $18.72 1,157 $21,661.35 48,503 SEC Form 4
Maney Rochelle L. AORT VP, Quality Mar 1 '24 Sell $18.72 1,157 $21,661.82 46,536 SEC Form 4
Stanton Marshall S. AORT SVP, Clinical & MD Affair Mar 1 '24 Sell $18.72 1,506 $28,195.48 85,479 SEC Form 4
Maney Rochelle L. AORT VP, Quality Mar 1 '24 Sell $18.72 1,157 $21,661.82 46,569 SEC Form 4
Holloway Jean F AORT SVP, General Counsel Mar 1 '24 Sell $18.72 2,380 $44,558.84 169,711 SEC Form 4
GREEN ANDREW M AORT VP Regulatory Mar 1 '24 Sell $18.72 1,160 $21,717.64 46,541 SEC Form 4
Stanton Marshall S. AORT SVP, Clinical & MD Affair Mar 1 '24 Sell $18.72 1,506 $28,195.48 85,438 SEC Form 4
Horton Amy AORT VP, Chief Accounting Officer Mar 1 '24 Sell $18.72 1,152 $21,568.09 139,957 SEC Form 4
Holloway Jean F AORT SVP, General Counsel Feb 27 '24 Sell $19.83 485 $9,619.68 166,325 SEC Form 4
Davis John E AORT Chief Commercial Officer Feb 27 '24 Sell $19.83 584 $11,583.29 161,935 SEC Form 4
Maney Rochelle L. AORT VP, Quality Feb 27 '24 Sell $19.83 370 $7,338.76 44,115 SEC Form 4
Stanton Marshall S. AORT SVP, Clinical & MD Affair Feb 27 '24 Sell $19.83 465 $9,223.00 81,261 SEC Form 4
GREEN ANDREW M AORT VP Regulatory Feb 27 '24 Sell $19.83 421 $8,350.28 44,159 SEC Form 4
Horton Amy AORT VP, Chief Accounting Officer Feb 27 '24 Sell $19.83 325 $6,446.18 137,563 SEC Form 4
GREEN ANDREW M AORT VP Regulatory Feb 27 '24 Sell $19.83 421 $8,350.28 44,123 SEC Form 4
Maney Rochelle L. AORT VP, Quality Feb 27 '24 Sell $19.83 370 $7,338.76 44,148 SEC Form 4
Mackin James P AORT President & CEO Feb 27 '24 Sell $19.83 4,837 $95,939.48 690,940 SEC Form 4

Share on Social Networks: